Stocklytics Platform
Asset logo for symbol ACLX
Arcellx
ACLX53
$77.29arrow_drop_up0.65%$0.50
Asset logo for symbol ACLX
ACLX53

$77.29

arrow_drop_up0.65%

Performance History

Chart placeholder
Key Stats
Open$76.63
Prev. Close$76.79
EPS-0.71
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range75.50
78.45
52 Week Range30.88
111.51
Ratios
EPS-0.71

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Arcellx (ACLX)

Arcellx, Inc. (ACLX) is a biotechnology company that focuses on the development of novel cell therapies for the treatment of cancer and other diseases. The company is headquartered in Gaithersburg, Maryland and was founded in 2015. Arcellx is committed to bringing innovative therapies to patients by harnessing the power of the immune system to selectively target and eliminate cancer cells. The company's platform technology, known as ARC-SparX, enables the engineering of highly potent and specific T cells to recognize and kill cancer cells. This approach has the potential to revolutionize cancer treatment by providing a more targeted and effective therapy.
Arcellx's stock price history reflects the growing interest and excitement surrounding the company's innovative cell therapy platform. Since going public, the stock has experienced significant growth, driven by positive clinical trial results and increasing investor confidence. The stock has seen strong momentum over the past year, reaching new highs and outperforming the broader market. Investors have been drawn to Arcellx's potential to disrupt the cancer treatment landscape and provide a more effective and personalized approach to therapy.
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Rami Elghandour
Headquarters
Gaithersburg
Employees
98
Exchange
NASDAQ
add Arcellx to watchlist

Keep an eye on Arcellx

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Arcellx's (ACLX) price per share?

The current price per share for Arcellx (ACLX) is $77.3. The stock has seen a price change of $0.5 recently, indicating a 0.65% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Arcellx (ACLX)?

For Arcellx (ACLX), the 52-week high is $111.51, which is 44.26% from the current price. The 52-week low is $30.88, the current price is 150.31% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Arcellx (ACLX) a growth stock?

Arcellx (ACLX) has shown an average price growth of -5.34% over the past three years. It has received a score of 89 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Arcellx as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Arcellx (ACLX) stock price performance year to date (YTD)?

As of the latest data, Arcellx (ACLX) has a year-to-date price change of 37.66%. Over the past month, the stock has experienced a price change of -13.55%. Over the last three months, the change has been -10.1%. Over the past six months, the figure is 37.86%.
help

Is Arcellx (ACLX) a profitable company?

Arcellx (ACLX) has a net income of -$70.69M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -129.14% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $110.32M, although specific revenue growth data is currently not available. The gross profit is $110.32M. Operating income is noted at -$89.88M. Furthermore, the EBITDA is -$65.3M.
help

What is the market capitalization of Arcellx (ACLX)?

Arcellx (ACLX) has a market capitalization of $4.11B. The average daily trading volume is 76.55, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level